The impact of intratumor heterogeneity on outcome and resistance to therapy in primary breast cancer: a systematic review
Aria Dianati, Andre Dekker, Anke Wesselius, Leonard Wee · 2026
Read The impact of intratumor heterogeneity on outcome and resistance to therapy in primary breast cancer: a systematic review by Aria Dianati, Andre Dekker, Anke Wesselius, Leonard Wee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634018.txt.
Description
Aria Dianati, Andre Dekker, Anke Wesselius, and Leonard Wee reviewed how variety inside a single breast tumor affects chemotherapy results, in this 2026 systematic review. A tumor is not uniform: it holds many cell subclones. That inner variety may let some cells survive treatment and seed relapse, yet clinics rarely measure it.
Following standard review methods, the team searched three databases and kept twelve studies across the main breast cancer types. Tumors with high or rising inner variety responded worse to chemotherapy. The review names several routes to resistance, from hardy clones being selected to cells changing form. Scans that read variety from images added predictive value, and models mixing scan and gene data did best. The authors call for trials before routine use.
Catalog record
| CREATOR | Aria Dianati, Andre Dekker, Anke Wesselius, Leonard Wee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |